Mitoguazone (Methyl-GAG) is a selective S-adenosyl-methionine decarboxylase inhibitor that penetrates the blood-brain barrier and disrupts polyamine biosynthesis. Mitoguazone is a synthetic polycarbonyl derivative with anti-tumor activity that inhibits the integration of HIV DNA into cellular DNA in monocytes and macrophages, inducing apoptosis. Mitoguazone can be used to prevent acute leukemia, Hodgkin lymphoma and non-Hodgkin lymphoma.
Molecular Weight:
184.2
Purity:
98.00%
CAS Number:
[459-86-9]
Formula:
C5H12N8
Target:
Apoptosis|||HIV Protease
T35617
* VAT and and shipping costs not included. Errors and price changes excepted